VERTEX PHARMACEUTICALS Revenue, Growth & Competitor Profile

DBA VERTEX PHARMACEUTICALS INC / MA

Company Profile & Annual Report for Vertex Pharmaceuticals

Access the complete profile.

Vertex Pharmaceuticals Fast Facts

Revenue	$10 - $50 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	50 Northern Ave Boston, MA 02210 www.vrtx.com

Vertex Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
• What industry is the company in?

Vertex Pharmaceuticals is a publicly traded company on NMS using the ticker symbol VRTX. Detailed information on company financials and operating reports can be found here: NMS: VRTX

Vertex Pharmaceuticals Annual Revenue and Growth Rate

Vertex Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2018	Details in Premium Report
2017
2016
2015
2014
2013
2012

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Vertex Pharmaceuticals's revenues are gauged from an analysis of company filings.

Investor Activity

Vertex Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
March 18, 2009	3	100%	$2 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Vertex Pharmaceuticals is developing and marketing. Vertex Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
VERTEX THE VERTEX FOUNDATION Charitable services, namely, promoting public awareness of serious diseases and their treatments	10/10/2019
CFSOURCE Providing health information; providing health care information by means of a website	09/10/2019
VERTEX GENETIC THERAPIES house mark for pharmaceutical preparations; nucleic acid medicines; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy	08/14/2019

See all trademarks and details in the Full Report.

Recession Risk

Determine whether Vertex Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Vertex Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.

Market Share of Vertex Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Vertex Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
SRI INTERNATIONAL	Menlo Park, CA	100
COLD SPRING HARBOR LABORATORY	Cold Spring Harbor, NY	47
QUINTILES	Durham, NC	14
OMNICARE	Cincinnati, OH	13
SYNEOS HEALTH	Raleigh, NC	8
ALEXION PHARMACEUTICALS	New Haven, CT	7
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	6
LEIDOS	Reston, VA	6
BECHTEL MARINE PROPULSION	West Mifflin, PA	6

Nearby Competitors

These companies are similar in business line and location to Vertex Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EMULATE	Boston, MA	100
CYTONOME ST.	Boston, MA	96
908 DEVICES	Boston, MA	92
VERTEX PHARMACEUTICALS	Boston, MA	91
BAIM INSTITUTE FOR CLINICAL RESEARCH	Boston, MA	91
FASTCAP SYSTEMS	Boston, MA	89

Future Competition: Vertex Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Vertex Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)